A Study of LY3039478 in Participants With Advanced Cancer

Clinical trial NCT01695005 · COMPLETED

Trial details

NCT number: NCT01695005
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Neoplasm Metastasis Lymphoma

Start date: 2012-10-01
Primary completion: 2018-06-26
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.